Keyphrases
P16INK4a Expression
66%
Venous Thromboembolism
50%
P16INK4a
50%
Senescence
50%
Aging
50%
Venous Thrombosis
50%
Thrombosis
16%
Cellular Senescence
16%
Vascular Injury
11%
Increasing Age
11%
Transgenic
11%
Regenerability
11%
Hemostasis System
11%
Physiological Significance
11%
Cell Cycle Inhibitors
11%
Endothelial Cells
5%
Murine Model
5%
Tumor Suppressor Activity
5%
Hemostasis
5%
Anticancer
5%
Platelets
5%
Grant Proposal
5%
Pathophysiology
5%
Blood Cells
5%
Model in Vitro
5%
Overexpressing
5%
Age-associated
5%
Risk Factors
5%
Self-renewal
5%
Stem Cells
5%
Vascular System
5%
Cardiovascular Disease
5%
C57BL
5%
Aged Mice
5%
Functional Role
5%
Cancer Tumor
5%
Inhibitor Protein
5%
Vascular Stasis
5%
Ageing Function
5%
Molecular Properties
5%
Cell Properties
5%
Vasculature
5%
Growth Arrest
5%
In Vitro Assay
5%
Monocytes
5%
Biochemistry, Genetics and Molecular Biology
Phlebothrombosis
100%
Mouse
22%
Transgenics
22%
Hemostasis
22%
Cell Cycle
11%
Hemocyte
11%
Monocyte
11%
Tumor Suppressor Protein
11%
Platelet
11%
Vascularization
11%
Stem Cell
11%
Murine
11%
Medicine and Dentistry
Venous Thromboembolism
50%
Phlebothrombosis
50%
Thrombosis
16%
Cellular Senescence
16%
Blood Vessel Injury
11%
Blood Stasis
11%
Tumor Suppressor Protein
5%
Inhibitor Protein
5%
Cyclin Dependent Kinase Inhibitor 2A
5%
Growth Disorder
5%
Cardiovascular Disease
5%
Stem Cell
5%
Cell Cycle
5%
Blood Cell
5%
Endothelial Cell
5%
Monocyte
5%
In Vitro
5%
Platelet
5%
Pathophysiology
5%
C57BL/6
5%
Malignant Neoplasm
5%
Vascularity
5%